Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
Near-patient testing (NPT) allows clinical decisions to be made in a rapid and convenient manner and is often cost effective. In COPD the peripheral blood eosinophil count has been demonstrated to have utility in providing prognostic information and predicting response to treatment during an acute e...
Prif Awduron: | Hambleton, K, Connolly, C, Borg, C, Davies, J, Jeffers, H, Russell, R, Bafadhel, M |
---|---|
Fformat: | Journal article |
Cyhoeddwyd: |
Dove Press
2017
|
Eitemau Tebyg
-
Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
gan: Hambleton, K, et al.
Cyhoeddwyd: (2016) -
The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
gan: Shrimanker, R, et al.
Cyhoeddwyd: (2017) -
Characterising non-eosinophilic COPD
gan: Hambleton, K, et al.
Cyhoeddwyd: (2015) -
Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
gan: Jeffers, H, et al.
Cyhoeddwyd: (2017) -
Investigating blood eosinophil count thresholds in patients with COPD
gan: Russell, R, et al.
Cyhoeddwyd: (2018)